As a volunteer, you’ll join thousands of people across the country who are helping add tomorrows to the lives of people with cystic fibrosis.
Site Search
The Cystic Fibrosis Foundation's successful business model was at the center of a congressional briefing in Washington, D.C., today, which focused on strategies for jump-starting drug development for rare diseases.
The Cystic Fibrosis Foundation has announced the recipients of its first annual Impact Grants.
Recipients include eight innovative programs from around the country that serve the CF community.
Corbus Pharmaceuticals reported promising results Thursday from an early stage clinical study of a potential anti-inflammatory drug for people with cystic fibrosis.
Watch the entire leadership conference, including all of the break-out sessions and Medical Hot Topics, from start to finish.
This year’s awardees showcase the diversity of journeys in the cystic fibrosis community.
CF Foundation President and CEO Robert J. Beall, Ph.D. testified today before the House of Representatives' Energy and Commerce Committee at a hearing entitled, “21st Century Cures: Incorporating the Patient Perspective.”
The Cystic Fibrosis Foundation awarded Talee Bio Inc. up to $4.5 million to develop methods for delivering potential gene therapy treatments to the lungs.